These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14455154)

  • 1. Massive estrogen administration in premenopausal women with advanced breast cancer.
    KENNEDY BJ
    Cancer Chemother Rep; 1962 Feb; 16():283-4. PubMed ID: 14455154
    [No Abstract]   [Full Text] [Related]  

  • 2. Massive estrogen administration in premenopausal women with metastatic breast cancer.
    KENNEDY BJ
    Cancer; 1962; 15():641-8. PubMed ID: 14455155
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the problem of hormone therapy of patients with far advanced stages of cancer of the breast].
    SVIATUKHINA OV
    Vopr Onkol; 1959; 5():556-64. PubMed ID: 13835956
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostatic metastases to the breast. Effect of estrogen.
    PRIBE WA
    J Mich State Med Soc; 1962 Aug; 61():962-3. PubMed ID: 14488716
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of premenopausal patients with advanced or recurrent breast cancer by chemical ablation].
    Sun Q; Huang HY; Zhou YD; Mao F; Yang YQ; Xing Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Feb; 25(1):60-2. PubMed ID: 12905610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the role of estrogens in mastopathy and breast cancer].
    BACIGALUPO G
    Dapim Refuiim; 1962 Feb; 17():180-7. PubMed ID: 13863753
    [No Abstract]   [Full Text] [Related]  

  • 7. Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer.
    Torrisi R; Bagnardi V; Rotmensz N; Scarano E; Iorfida M; Veronesi P; Luini A; Viale G; Santoro A; Colleoni M; Goldhirsch A
    Breast Cancer Res Treat; 2011 Apr; 126(2):431-41. PubMed ID: 21221766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian ablation for premenopausal breast cancer: A review of treatment considerations and the impact of premature menopause.
    Nourmoussavi M; Pansegrau G; Popesku J; Hammond GL; Kwon JS; Carey MS
    Cancer Treat Rev; 2017 Apr; 55():26-35. PubMed ID: 28288389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases.
    El-Saghir NS; El-Hajj II; Makarem JA; Otrock ZK
    Anticancer Drugs; 2006 Sep; 17(8):999-1002. PubMed ID: 16940812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced progesterone levels explain the reduced risk of breast cancer in obese premenopausal women: a new hypothesis.
    Dowsett M; Folkerd E
    Breast Cancer Res Treat; 2015 Jan; 149(1):1-4. PubMed ID: 25414027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormone therapy and breast cancer].
    RAVAULT PP; MORNEX R
    J Med Lyon; 1962 Jan; 43():139-48. PubMed ID: 14490624
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hormonal treatment of cancer of the breast].
    REMY EF
    Dia Med; 1961 Oct; 33():2322-8. PubMed ID: 14491433
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant endocrine therapy for premenopausal women: Type and duration.
    Francis PA
    Breast; 2017 Aug; 34 Suppl 1():S108-S111. PubMed ID: 28669713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incomplete Estrogen Suppression With Gonadotropin-Releasing Hormone Agonists May Reduce Clinical Efficacy in Premenopausal Women With Early Breast Cancer.
    Dowsett M; Lønning PE; Davidson NE
    J Clin Oncol; 2016 May; 34(14):1580-3. PubMed ID: 26729430
    [No Abstract]   [Full Text] [Related]  

  • 16. Estrogen-replacement therapy in younger women with breast cancer.
    Theriault RL; Sellin RV
    J Natl Cancer Inst Monogr; 1994; (16):149-52. PubMed ID: 7999457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical development of estrogen modulators for breast cancer chemoprevention in premenopausal vs. postmenopausal women.
    Lawrence JA; Malpas PB; Sigman CC; Kelloff GJ
    J Cell Biochem Suppl; 2000; 34():103-14. PubMed ID: 10762022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of advanced mammary cancer with estrogens.
    CUTLER M; SCHLEMENSON M
    Surgery; 1949 Oct; 26(4):567-72. PubMed ID: 18141327
    [No Abstract]   [Full Text] [Related]  

  • 19. [Standards, Options and Recommendations (SOR) for endocrine therapy in patients with non metastatic breast cancer. FNCLCC].
    Mauriac L; Blanc-Vincent MP; Luporsi E; Cutuli B; Fourquet A; Garbay JR; Giard S; Spyratos F; Zafrani B; Dilhuydy JM
    Bull Cancer; 2000 Jun; 87(6):469-90. PubMed ID: 10903789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adjuvant endocrine therapy in premenopausal breast cancer].
    Bando H
    Nihon Rinsho; 2012 Sep; 70 Suppl 7():627-35. PubMed ID: 23350475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.